#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14470	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2077	692.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1424	1424	C	820	C	764	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25634	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3564	717.1	0	.	n	.	0	A20C	SNP	20	20	A	390	390	C	463	C,A	439,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25634	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3564	717.1	0	.	n	.	0	T695C	SNP	695	695	T	1065	1065	C	772	C,T	723,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25634	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3564	717.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	2008	2008	G	901	G	855	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25634	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3564	717.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2341	2341	C	761	C,T	704,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25634	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3564	717.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2415	2415	A	812	A	772	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25634	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3564	717.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2967	2967	C	843	C	796	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1898	folP	855	855	100.0	folP.l15.c30.ctg.1	1643	115.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1112	1114	AGC	181;180;180	A;G;C	173;173;171	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5044	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3461	145.5	1	SNP	p	S91F	1	.	.	271	273	TTC	669	671	TTC	180;177;177	T;T;C,T	169;167;167,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5044	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3461	145.5	1	SNP	p	G95N	0	.	.	283	285	GGC	681	683	GGC	167;168;171	G;G;C	158;158;158	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5044	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3461	145.5	1	SNP	p	D95G	1	.	.	283	285	GGC	681	683	GGC	167;168;171	G;G;C	158;158;158	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1500	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1240	120.3	0	.	p	.	0	F184L	NONSYN	550	552	TTC	834	836	TTG	160;163;164	T;T;G	146;149;150	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1500	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1240	120.3	1	SNP	p	G45D	0	.	.	133	135	GGC	417	419	GGC	208;206;203	G;G;C	196;194;191	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	770	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	967	78.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4842	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3198	150.9	1	SNP	p	D86N	0	.	.	256	258	GAC	726	728	GAC	200;203;202	G;A,C;C	189;187,1;189	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4842	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3198	150.9	1	SNP	p	R87I	0	.	.	259	261	CGT	729	731	CGT	203;207;207	C;G;T	191;190;189	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4842	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3198	150.9	1	SNP	p	S87R	1	.	.	259	261	CGT	729	731	CGT	203;207;207	C;G;T	191;190;189	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4842	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3198	150.9	1	SNP	p	R87W	0	.	.	259	261	CGT	729	731	CGT	203;207;207	C;G;T	191;190;189	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4842	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3198	150.9	1	SNP	p	S88P	0	.	.	262	264	TCC	732	734	TCC	207;207;206	T;C,A;C	190;190,1;193	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4058	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2719	148.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1520	1522	GGC	207;209;204	G;G;C	186;186;184	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2381	151.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1260	1262	GCA	209;205;208	G;C;A	192;190;194	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2381	151.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1263	1265	ATC	208;209;211	A;T;C	197;196;199	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2381	151.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1275	1277	GTG	201;202;202	G,T;T;G	193,1;194;192	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2381	151.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1275	1277	GTG	201;202;202	G,T;T;G	193,1;194;192	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2381	151.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1779	1781	ACC	183;179;179	A;C;C	174;173;172	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2381	151.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1833	1835	GCG	179;179;178	G;C;G	162;143;155	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2381	151.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1833	1835	GCG	179;179;178	G;C;G	162;143;155	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2381	151.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1956	1958	AGC	168;166;165	A;G;C,G	157;157;155,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2381	151.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1965	1967	GGC	158;157;157	G,A;G;C	146,1;148;143	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3634	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2381	151.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1983	1985	CCG	150;151;151	C,G;C,G;G,A	113,2;115,1;116,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5256	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3142	166.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1629	1631	CCG	173;172;171	C;C;G	154;160;155	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1950	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1822	106.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	509	509	C	121	C	118	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2806	porB1b	1038	1038	96.28	porB1b.l15.c30.ctg.1	1323	206.7	0	.	p	.	0	I45V	NONSYN	133	135	ATT	281	283	GTT	250;250;253	G;T;T	241;238;242	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2806	porB1b	1038	1038	96.28	porB1b.l15.c30.ctg.1	1323	206.7	0	.	p	.	0	N121S	NONSYN	361	363	AAC	509	511	AGC	210;209;209	A;G;C	196;197;197	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2806	porB1b	1038	1038	96.28	porB1b.l15.c30.ctg.1	1323	206.7	0	.	p	.	0	N122K	NONSYN	364	366	AAC	512	514	AAA	210;205;201	A;A;A	196;195;189	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2806	porB1b	1038	1038	96.28	porB1b.l15.c30.ctg.1	1323	206.7	0	.	p	.	0	F131H	NONSYN	391	393	TTT	539	541	CAT	205;205;206	C;A;T	197;197;198	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2806	porB1b	1038	1038	96.28	porB1b.l15.c30.ctg.1	1323	206.7	0	.	p	.	0	N134E	NONSYN	400	402	AAT	548	550	GAG	210;209;210	G;A;G	205;202;205	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2806	porB1b	1038	1038	96.28	porB1b.l15.c30.ctg.1	1323	206.7	0	.	p	.	0	V135L	NONSYN	403	405	GTG	551	553	CTT	211;212;212	C;T;T	205;206;206	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2806	porB1b	1038	1038	96.28	porB1b.l15.c30.ctg.1	1323	206.7	0	.	p	.	0	G140K	NONSYN	418	420	GGA	566	568	AAA	207;208;207	A;A;A	199;201;200	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2806	porB1b	1038	1038	96.28	porB1b.l15.c30.ctg.1	1323	206.7	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	575	577	GAA	202;205;202	G;A;A	192;194;191	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2806	porB1b	1038	1038	96.28	porB1b.l15.c30.ctg.1	1323	206.7	0	.	p	.	0	V151A	NONSYN	451	453	GTA	599	601	GCA	213;212;214	G;C,T;A	204;201,1;201	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2806	porB1b	1038	1038	96.28	porB1b.l15.c30.ctg.1	1323	206.7	0	.	p	.	0	K207_M208insK	INS	619	619	A	767	767	A	229	A	215	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2806	porB1b	1038	1038	96.28	porB1b.l15.c30.ctg.1	1323	206.7	0	.	p	.	0	G210R	NONSYN	628	630	GGA	779	781	AGA	223;218;215	A;G;A	211;207;204	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2806	porB1b	1038	1038	96.28	porB1b.l15.c30.ctg.1	1323	206.7	0	.	p	.	0	A212S	NONSYN	634	636	GCA	785	787	TCA	215;216;215	T;C;A	204;206;205	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2806	porB1b	1038	1038	96.28	porB1b.l15.c30.ctg.1	1323	206.7	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	902	902	T	188	T	182	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10444	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4788	217.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1250	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1105	112.8	1	SNP	p	V57M	1	.	.	169	171	ATG	574	576	ATG	245;243;242	A;T;G	240;239;236	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
